STOCK TITAN

Nu Skin (NUS) CFO has 11,725 shares withheld to cover RSU taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nu Skin Enterprises Chief Financial Officer Thomas James reported a tax-related share disposition. On the vesting of previously granted restricted stock units, 11,725 shares of Class A common stock were withheld to cover tax obligations at $8.36 per share. After this tax-withholding disposition, he directly owns 180,998 shares of Nu Skin Enterprises Class A common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Thomas James D

(Last) (First) (Middle)
C/O NU SKIN ENTERPRISES, INC.
75 W CENTER STREET

(Street)
PROVO UT 84601

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 02/15/2026 F 11,725(1) D $8.36 180,998 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.
/s/ Gregory Belliston as Attorney-in-Fact for James D. Thomas 02/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Nu Skin (NUS) disclose for CFO Thomas James?

Nu Skin (NUS) disclosed that CFO Thomas James had 11,725 Class A common shares withheld to cover taxes on vesting restricted stock units. This tax-withholding disposition is not an open-market sale and follows the vesting of previously granted equity awards.

How many Nu Skin (NUS) shares were involved in the CFO’s Form 4 filing?

The Form 4 shows 11,725 Nu Skin Class A common shares were withheld to satisfy tax withholding obligations. These shares relate to the vesting of previously granted restricted stock units rather than a discretionary market transaction or new share purchase.

At what price were the Nu Skin (NUS) shares valued for the CFO’s tax withholding?

The withheld Nu Skin shares were valued at $8.36 per share for tax withholding purposes. This value applies to the 11,725 Class A common shares used to cover obligations triggered by the vesting of earlier restricted stock unit grants.

How many Nu Skin (NUS) shares does the CFO own after this transaction?

After the tax-withholding disposition, CFO Thomas James directly owns 180,998 Nu Skin Class A common shares. This figure reflects his remaining direct holdings following the automatic withholding of 11,725 shares tied to restricted stock unit vesting.

Was the Nu Skin (NUS) CFO’s Form 4 transaction an open-market sale?

No, the transaction was not an open-market sale. The Form 4 and its footnote state the 11,725 Nu Skin shares were withheld solely to satisfy tax obligations arising from vesting restricted stock units previously granted to the CFO.
Nu Skin Enter

NYSE:NUS

NUS Rankings

NUS Latest News

NUS Latest SEC Filings

NUS Stock Data

414.37M
45.82M
Household & Personal Products
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
PROVO